India is ready to increase the supply of medicines to China, where an outbreak of COVID-19 has been noted

India, one of the largest pharmaceutical manufacturers in the world, is ready to increase the export of medicines, including ibuprofen and paracetamol, to China, where the incidence of covid has increased.

This was reported to journalists by the Chairman of the Pharmaceutical Export Promotion Council of India (Pharmexcil) Sahil Munjal.
"India is ready to export antipyretic drugs to China. <...> Marketing requests come to pharmaceutical manufacturers, asking for quotes for ibuprofen and paracetamol," the Times Now TV channel quoted Munjal as saying on Friday. "Ibuprofen and paracetamol are currently in short supply in China and are in high demand," Munjal added.
At a press briefing on Thursday, Indian Foreign Ministry spokesman Arindam Bagchi said that New Delhi is closely monitoring the situation with coronavirus in China, and also recalled that India "has always helped other countries as a recognized "pharmacy of the world."
As the TV channel points out, so far the export of medicines from India to China is small. According to the latest Pharmexcil annual report, India's pharmaceutical supplies to China in 2021-2022 accounted for about 1.4% of its total drug exports. The main export market for Indian medicines is the USA. On the news of covid outbreaks in a number of countries, the shares of Indian pharmaceutical companies have been growing in the last few days, writes TASS.